Ventricular Tachycardia (VT) is a cardiac arrhythmia characterized by a rapid and regular heartbeat originating in the heart's lower chambers, the ventricles. In VT, the heart beats at a significantly faster rate than normal, disrupting its regular rhythm. This condition poses serious health risks as it may lead to inadequate blood flow to the body and, in severe cases, progress to more life-threatening arrhythmias. Ventricular Tachycardia can occur in individuals with pre-existing heart conditions, such as coronary artery disease or structural heart abnormalities, but it can also manifest in those with otherwise healthy hearts. Prompt diagnosis and management are crucial to prevent complications and improve patient outcomes, often involving anti-arrhythmic medications, catheter ablation, or, in severe cases, implantable cardioverter-defibrillator (ICD) placement. Regular monitoring and collaboration between healthcare professionals play a vital role in effectively addressing Ventricular Tachycardia and ensuring the well-being of affected individuals.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain